CA2769640A1 - Combinaison du dapsone avec l'adapalene - Google Patents

Combinaison du dapsone avec l'adapalene Download PDF

Info

Publication number
CA2769640A1
CA2769640A1 CA2769640A CA2769640A CA2769640A1 CA 2769640 A1 CA2769640 A1 CA 2769640A1 CA 2769640 A CA2769640 A CA 2769640A CA 2769640 A CA2769640 A CA 2769640A CA 2769640 A1 CA2769640 A1 CA 2769640A1
Authority
CA
Canada
Prior art keywords
composition
adapalene
dapsone
treatment
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2769640A
Other languages
English (en)
Inventor
Gurpreet Ahluwalia
Kevin S. Warner
Haigang Chen
Meidong Yang
Frederick C. Beddingfield
Jeffrey R. Ehrhardt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of CA2769640A1 publication Critical patent/CA2769640A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
CA2769640A 2009-07-30 2010-07-29 Combinaison du dapsone avec l'adapalene Abandoned CA2769640A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22990309P 2009-07-30 2009-07-30
US61/229,903 2009-07-30
PCT/US2010/043671 WO2011014627A1 (fr) 2009-07-30 2010-07-29 Combinaison du dapsone avec l'adapalene

Publications (1)

Publication Number Publication Date
CA2769640A1 true CA2769640A1 (fr) 2011-02-03

Family

ID=42953716

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2769640A Abandoned CA2769640A1 (fr) 2009-07-30 2010-07-29 Combinaison du dapsone avec l'adapalene

Country Status (6)

Country Link
EP (1) EP2459172A1 (fr)
JP (1) JP2013500984A (fr)
AU (1) AU2010278915A1 (fr)
CA (1) CA2769640A1 (fr)
RU (1) RU2012104572A (fr)
WO (1) WO2011014627A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110117182A1 (en) * 2009-07-30 2011-05-19 Allergan, Inc. Combination of dapsone with other anti-acne agents
JP2013527161A (ja) * 2010-04-29 2013-06-27 ガルデルマ・リサーチ・アンド・デヴェロップメント アダパレン０．３％による瘢痕の処置方法
CA2829040A1 (fr) * 2011-03-03 2012-09-07 Allergan, Inc. Formulations ophtalmiques non aqueuses a base de silicone
KR20140081783A (ko) * 2011-06-30 2014-07-01 알러간, 인코포레이티드 피부 질환을 치료하기 위한 레티노이드 국소 조성물 및 방법
DK2922528T3 (en) * 2012-11-20 2017-09-18 Allergan Inc TOPICAL DAPSON AND DAPSON / ADAPALEN COMPOSITIONS AND PROCEDURES FOR USE THEREOF
WO2016136925A1 (fr) * 2015-02-27 2016-09-01 マルホ株式会社 Composition pour la peau
JP6508681B2 (ja) * 2016-01-18 2019-05-08 基嗣 田島 ケミカルピーリング剤
CA3070663A1 (fr) * 2017-07-21 2019-01-24 Almirall, Llc Traitement de lesions non inflammatoires
JP7299766B2 (ja) * 2018-06-16 2023-06-28 ロート製薬株式会社 外用組成物
WO2019240290A1 (fr) * 2018-06-16 2019-12-19 ロート製薬株式会社 Composition topique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030157036A1 (en) * 2002-02-20 2003-08-21 Osborne David W. Topical dapsone for the treatment of acne
KR20070091613A (ko) * 2004-11-08 2007-09-11 그렌마크 파머수티칼스 엘티디. 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물
MXPA06008988A (es) * 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
US20100029781A1 (en) * 2008-06-04 2010-02-04 Morris Jerome A Methods for preparation of anti-acne formulation and compositions prepared thereby

Also Published As

Publication number Publication date
WO2011014627A1 (fr) 2011-02-03
RU2012104572A (ru) 2013-09-10
EP2459172A1 (fr) 2012-06-06
JP2013500984A (ja) 2013-01-10
AU2010278915A1 (en) 2012-03-01

Similar Documents

Publication Publication Date Title
US20110117182A1 (en) Combination of dapsone with other anti-acne agents
CA2769640A1 (fr) Combinaison du dapsone avec l'adapalene
DK2450035T3 (en) Combination of adapalene and benzoyl peroxide for the treatment of acne lesions
US20110318434A1 (en) Acne Vulgaris Treatment Regimen
US20120087876A1 (en) Avermectin/metronidazole compositions for treating afflictions of the skin, e.g., rosacea
US20090191245A1 (en) Reduced-irritant dermatological compositions comprising at least one naphthoic acid compound and benzoyl peroxide and treatment of keratinization disorders therewith
CA2742389A1 (fr) Traitement topique d'une infection de la peau
US20150342920A1 (en) Dermatological compositions comprising at least one retinoid compound, an anti-irritant compound and benzoyl peroxide
US20110178049A1 (en) Avermectin/hydrocortisone compositions for treating afflictions of the skin. e.g., rosacea
US20090098219A1 (en) Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith
JP5275811B2 (ja) 少なくとも１種のレチノイド化合物と、少なくとも１種の抗刺激剤化合物とを含む組成物およびその使用
EP4169512A1 (fr) Composition dermatologique comprenant des oléosomes et des rétinoïdes, son procédé de préparation et son utilisation
US20110305747A1 (en) Combination of dapsone with other anti-acne agents
CA2762394C (fr) Solutions de retinoides topiques
US8716341B2 (en) Topically applicable compositions for the treatment of keratinization disorders
US10022348B2 (en) Topical solution of isotretinoin
WO2007138231A1 (fr) Compositions comprenant au moins un dérivé de l'acide naphtoïque et au moins un agent filmogène, leurs procédés de préparation, et leurs utilisations
WO2022140467A1 (fr) Compositions topiques et procédés de traitement de maladies et d'états cutanés avec de telles compositions

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20150729